(Q43061646)

13 November 2017

title

Pharmacological treatment of refractory breathlessness (English)

1 reference

13 November 2017

1 reference

1

1 reference

13 November 2017

Claudia Bausewein

2

0 references

Irene Higginson

object named as

Irene Higginson

series ordinal

3

0 references

author name string

Shakeeb H Moosavi

series ordinal

4

1 reference

13 November 2017

publication date

1 February 2009

1 reference

Expert Review of Respiratory Medicine

13 November 2017

published in

1 reference

13 November 2017

volume

3

1 reference

13 November 2017

issue

1

1 reference

13 November 2017

page(s)

21-36

1 reference

A comparison of the palliative care needs of patients dying from chronic respiratory diseases and lung cancer.

13 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

Palliation of symptoms in non-small cell lung cancer: a study by the Yorkshire Regional Cancer Organisation Thoracic Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

Pathophysiology of dyspnea in chronic obstructive pulmonary disease: a roundtable

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

Respiratory sensations in subjects who lack a ventilatory response to CO2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

The etiology and management of intractable breathlessness in patients with advanced cancer: a systematic review of pharmacological therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

Cortical substrates for the perception of dyspnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

The unpleasantness of perceived dyspnea is processed in the anterior insula and amygdala

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

Illness trajectories and palliative care

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

Does oxygen help dyspnea in patients with cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

A systematic review of the use of opioids in the management of dyspnoea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

Morphine for the relief of breathlessness in patients with chronic heart failure--a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

Advanced chronic obstructive pulmonary disease: innovative approaches to palliation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

Clinical experience with transdermal and orally administered opioids in palliative care patients--a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

Nebulized fentanyl citrate improves patients' perception of breathing, respiratory rate, and oxygen saturation in dyspnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

Oral transmucosal fentanyl citrate in the management of dyspnea crises in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

Effects of buspirone on anxiety levels and exercise tolerance in patients with chronic airflow obstruction and mild anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

Effect of alprazolam on exercise and dyspnea in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

The use of chlorpromazine for symptom control in dying cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

Anxiety and chronic obstructive pulmonary disease: prevalence, impact, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

The hospital anxiety and depression scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

Nebulized furosemide as a novel treatment for dyspnea in terminal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

Effect of nebulized furosemide in terminally ill cancer patients with dyspnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

Prevention of exercise-induced bronchoconstriction by inhaled frusemide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

Effects of inhaled furosemide on exertional dyspnea in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

Ambulatory oxygen improves quality of life of COPD patients: a randomised controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

A randomized, double-blind, crossover trial of the effect of oxygen on dyspnea in patients with advanced cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

Oxygen for relief of dyspnoea in mildly- or non-hypoxaemic patients with cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

The use of oxygen in the palliation of breathlessness. A report of the expert working group of the Scientific Committee of the Association of Palliative Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

The effect of helium and oxygen on exercise performance in chronic obstructive pulmonary disease: a randomized crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

A double-blind, randomised, controlled Phase II trial of Heliox28 gas mixture in lung cancer patients with dyspnoea on exertion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

'Air hunger' arising from increased PCO2 in mechanically ventilated quadriplegics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

'Air hunger' from increased PCO2 persists after complete neuromuscular block in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

Respiratory-associated thalamic activity is related to level of respiratory drive

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

Respiratory sensations during heavy exercise in subjects without respiratory chemosensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

Time course of air hunger mirrors the biphasic ventilatory response to hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

Acute partial paralysis alters perceptions of air hunger, work and effort at constant P(CO(2)) and V(E).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

Respiratory-associated rhythmic firing of midbrain neurons is modulated by vagal input

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

Intravenous adenosine and dyspnea in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

The pulmonary effects of intravenous adenosine in asthmatic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

Effects of airway anesthesia on dyspnea and ventilatory response to intravenous injection of adenosine in healthy human subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

Air hunger and ventilation in response to hypercapnia: effects of repetition and anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

The impact of emotions on the sensory and affective dimension of perceived dyspnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

Attentional distraction reduces the affective but not the sensory dimension of perceived dyspnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

Distractive auditory stimuli reduce the unpleasantness of dyspnea during exercise in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

Effects of inhaled furosemide on CO(2) ventilatory responsiveness in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

Re: nebulized furosemide for dyspnea in terminal cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

Oxygen Use—Patients Define Symptomatic Benefit Discerningly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

THE PERCEPTION OF MOTOR COMMANDS OR EFFORT DURING MUSCULAR PARALYSIS

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

Drug treatment of breathlessness: contrasting effects of diazepam and promethazine in pink puffers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17476348.3.1.21

21 January 2018

Identifiers

DOI

10.1586/17476348.3.1.21

1 reference

13 November 2017

1 reference